Berapakah harga Jiangsu Recbio Technology Co., Ltd. (2179)

Harga Jiangsu Recbio Technology Co., Ltd. (2179) adalah $0.63963115

Apakah topi pasaran Jiangsu Recbio Technology Co., Ltd. (2179)

Cap pasaran Jiangsu Recbio Technology Co., Ltd. (2179) adalah $339.16M

Jiangsu Recbio Technology Co., Ltd. (2179) Dividen

Jiangsu Recbio Technology Co., Ltd. operates as a biotechnology company primarily engaged in the pioneering research, development, and eventual market introduction of subunit vaccines throughout the People's Republic of China. A significant portion of its pipeline is dedicated to combating human papillomavirus (HPV)-related diseases, including cervical cancer and genital warts. Its most advanced candidate, REC603, is a recombinant 9-valent HPV vaccine currently undergoing Phase III clinical trials. Additionally, two bivalent HPV vaccines, REC601 and REC602, are progressing through Phase I trials. Further early-stage development includes the quadrivalent REC604a and 9-valent REC604b recombinant HPV vaccines, both in preclinical stages. Beyond HPV, the company boasts a diverse pipeline addressing other infectious diseases. Its COVID-19 efforts include ReCOV, a recombinant vaccine candidate in Phase II/III trials, and the preclinical messenger RNA (mRNA) candidate, R520A. Other preclinical projects target various conditions, such as the recombinant shingles vaccine REC610, the virus-vectored adult tuberculosis vaccine REC607, and its recombinant counterpart REC606. Also in preclinical development are the recombinant quadrivalent influenza vaccine REC617 and the recombinant quadrivalent hand-foot-mouth disease vaccine REC605. Established in 2011, Recbio Technology maintains its headquarters in Taizhou, People's Republic of China.

Tahun	Dividen (diselaraskan untuk pemecahan saham)	Ubah
Tidak cukup data untuk tarikh yang disediakan.

Tahun

Dividen (diselaraskan untuk pemecahan saham)

Ubah

Tidak cukup data untuk tarikh yang disediakan.

Tahun	Dividen	Ubah
Tidak cukup data untuk tarikh yang disediakan.

Tahun

Dividen

Ubah

Tidak cukup data untuk tarikh yang disediakan.

Syarikat	Jumlah pembayaran dividen	Negara
Vertex Pharmaceuticals Incorporated VRTX.US	0.00%	US
Argenx SE ARGX.US	0.00%	NL
CSL Limited CSL.AX	64.00%	AU
Moderna, Inc. MRNA.US	0.00%	US
Lonza Group AG LONN.SW	0.00%	CH

Syarikat

Jumlah pembayaran dividen

Negara